Cognate Nanovaccine Promotes Tertiary Lymphoid Structures Function and Strengthens Immune Cell Cross-Talk by Targeting Exhausted T Cells in Nonimmunogenic Cancers
ACS Nano · 2025
DOI: 10.1021/acsnano.5c01280 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2025. Verfasst von Gengjia Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510655, China. Hauptthemen laut MEDLINE: Nanoparticles, Pancreatic Neoplasms, T-Lymphocytes, Cancer Vaccines. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Guangzhou Municipal Science and Technology Bureau, National Natural Science Foundation of China.
Abstract (Originalsprache)
Tertiary lymphoid structures (TLSs) serve as hubs for immune cell activation and coordination to generate qualitative local immune responses within tumors. However, the effect of TLSs in pancreatic adenocarcinoma is limited by a poorly immunogenic tumor microenvironment and severe T-cell exhaustion. In this study, we found that tumor-infiltrating T cells, particularly TLS-associated T cells, predominantly exhibit terminal exhaustion characterized by high T-cell immunoglobulin and mucin domain-containing protein 3 (TIM-3) expression in patients with pancreatic cancer, affecting their contribution to antitumor immunity. Thus, we developed a therapeutic nanovaccine by fusing antigen-sensitized dendritic cell membranes with TIM-3-targeted lipid nanoparticles (MLP-aTIM-3) to synergistically reverse T-cell exhaustion. The prepared nanovaccine provides cognate antigens and costimulation to the exhausted T cells by the TIM-3/aTIM-3 interaction. In vitro and in vivo studies demonstrate that targeting T-cell exhaustion through the MLP-aTIM-3 not only restores T-cell reactivity but also promotes the formation and maturation of TLSs, leading to superior antitumor efficacy in an orthotopic pancreatic cancer model. Additionally, the therapeutic efficacy of MLP-aTIM-3 extends to other tumor models, such as liver metastasis and colorectal cancer. Our study suggests that targeting T-cell exhaustion while enhancing TLS function with MLP-aTIM-3 offers a promising strategy for improving the immune response in nonimmunogenic cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510655, China.
- Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510655, China.
- Department of Minimally Invasive Interventional Radiology, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou 510260, China.
- Nanomedicine Research Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.
ORCID-Profile: Bo Li, Xintao Shuai, Xiaochun Meng
Förderung
- China Postdoctoral Science Foundation
- Guangzhou Municipal Science and Technology Bureau
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Guangdong Basic Research Center of Excellence for Functional Molecular Engineering
Zitieren
APA
Chen, G., Li, T., Duan, R., Liang, W., Li, B., Xie, X., Yang, L., Shuai, X., & Meng, X. (2025). Cognate Nanovaccine Promotes Tertiary Lymphoid Structures Function and Strengthens Immune Cell Cross-Talk by Targeting Exhausted T Cells in Nonimmunogenic Cancers. ACS Nano. https://doi.org/10.1021/acsnano.5c01280
Vancouver
Chen G, Li T, Duan R, Liang W, Li B, Xie X, et al. Cognate Nanovaccine Promotes Tertiary Lymphoid Structures Function and Strengthens Immune Cell Cross-Talk by Targeting Exhausted T Cells in Nonimmunogenic Cancers. ACS Nano. 2025. doi:10.1021/acsnano.5c01280
BibTeX
@article{Chen2025,
author = {Chen, Gengjia and Li, Tan and Duan, Rui and Liang, Weiye and Li, Bo and Xie, Xiaoxue and Yang, Long and Shuai, Xintao and Meng, Xiaochun},
title = {Cognate Nanovaccine Promotes Tertiary Lymphoid Structures Function and Strengthens Immune Cell Cross-Talk by Targeting Exhausted T Cells in Nonimmunogenic Cancers},
journal = {ACS Nano},
year = {2025},
doi = {10.1021/acsnano.5c01280}
}
EUVIMED